UK markets open in 3 hours 22 minutes
  • NIKKEI 225

    23,486.35
    -30.24 (-0.13%)
     
  • HANG SENG

    24,918.78
    +132.68 (+0.54%)
     
  • CRUDE OIL

    39.14
    -0.71 (-1.78%)
     
  • GOLD FUTURES

    1,900.00
    -5.20 (-0.27%)
     
  • DOW

    28,335.57
    -28.13 (-0.10%)
     
  • BTC-GBP

    10,061.71
    +29.15 (+0.29%)
     
  • CMC Crypto 200

    263.53
    +2.07 (+0.79%)
     
  • ^IXIC

    11,548.28
    +42.28 (+0.37%)
     
  • ^FTAS

    3,310.38
    +41.84 (+1.28%)
     

Respiratory Disease Vaccine Market Research Report by Infection, by Type, by Age Group - Global Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·5-min read

Respiratory Disease Vaccine Market Research Report by Infection (Influenza Virus, Pertussis, Streptococcus Pneumoniae, and Tuberculosis), by Type (Bacterial Vaccine, Combination Vaccine, and Viral Vaccine), by Age Group - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Respiratory Disease Vaccine Market Research Report by Infection, by Type, by Age Group - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05941826/?utm_source=GNW

The Global Respiratory Disease Vaccine Market is expected to grow from USD 19,048.08 Million in 2019 to USD 25,236.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 4.80%.

Market Segmentation & Coverage:
This research report categorizes the Respiratory Disease Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:

"The Streptococcus Pneumoniae is projected to witness the highest growth during the forecast period"

Based on Infection, the Respiratory Disease Vaccine Market studied across Influenza Virus, Pertussis, Streptococcus Pneumoniae, and Tuberculosis. The Influenza Virus commanded the largest size in the Respiratory Disease Vaccine Market in 2019. On the other hand, the Streptococcus Pneumoniae is expected to grow at the fastest CAGR during the forecast period.

"The Combination Vaccine is projected to witness the highest growth during the forecast period"

Based on Type, the Respiratory Disease Vaccine Market studied across Bacterial Vaccine, Combination Vaccine, and Viral Vaccine. The Viral Vaccine commanded the largest size in the Respiratory Disease Vaccine Market in 2019. On the other hand, the Combination Vaccine is expected to grow at the fastest CAGR during the forecast period.

"The Adult Vaccination is projected to witness the highest growth during the forecast period"

Based on Age Group, the Respiratory Disease Vaccine Market studied across Adolescent Vaccination, Adult Vaccination, and Infant Vaccination. The Infant Vaccination commanded the largest size in the Respiratory Disease Vaccine Market in 2019. On the other hand, the Adult Vaccination is expected to grow at the fastest CAGR during the forecast period.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Respiratory Disease Vaccine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Respiratory Disease Vaccine Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Respiratory Disease Vaccine Market including AstraZeneca, Bavarian Nordic, Bayer AG, Bio Farma, Dynavax Technologies Corporation, Emergent BioSolutions, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Seqirus USA Inc., and Serum institute of India Private Limited.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Respiratory Disease Vaccine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Respiratory Disease Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Respiratory Disease Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Respiratory Disease Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Respiratory Disease Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Respiratory Disease Vaccine Market?
6. What are the modes and strategic moves considered suitable for entering the Global Respiratory Disease Vaccine Market?
Read the full report: https://www.reportlinker.com/p05941826/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001